T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLIR
1376
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.29M | ﹤0.01% |
200,210
-2,200
| -1% | -$68.7K |
|
|
FTR
1377
DELISTED
Frontier Communications Corp.
FTR
| $6.28M | ﹤0.01% |
100,356
-1,086
| -1% | -$70.6K |
|
|
WBMD
1378
DELISTED
WebMD Health Corp.
WBMD
| $6.23M | ﹤0.01% |
217,870
+23,400
| +12% | +$730K |
|
|
AAMC
1379
DELISTED
Altisource Asset Management Corp
AAMC
| $6.18M | ﹤0.01% |
+19,839
| New | +$4.83M |
|
1380
Protolabs
PRLB
$2.21B
| $6.15M | ﹤0.01% |
80,500
-201,060
| -71% | -$13.9M |
|
1381
Agios Pharmaceuticals
AGIO
$2B
| $6.09M | ﹤0.01% |
+218,000
| New | +$6.02M |
|
|
NSTG
1382
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.09M | ﹤0.01% |
+553,828
| New | +$5.01M |
|
1383
RenaissanceRe
RNR
$13.3B
| $6.08M | ﹤0.01% |
67,200
+1,100
| +2% | +$96K |
|
1384
CorVel
CRVL
$3.25B
| $6.05M | ﹤0.01% |
490,698
+42,000
| +9% | +$473K |
|
1385
Copart
CPRT
$27.2B
| $5.85M | ﹤0.01% |
1,471,200
+10,400
| +0.7% | +$42.3K |
|
|
PDCO
1386
DELISTED
Patterson Companies, Inc.
PDCO
| $5.84M | ﹤0.01% |
145,270
+4,300
| +3% | +$174K |
|
1387
Albemarle
ALB
$15.4B
| $5.83M | ﹤0.01% |
92,640
-200
| -0.2% | -$12.6K |
|
|
AKRX
1388
DELISTED
Akorn Inc
AKRX
| $5.8M | ﹤0.01% |
294,600
-16,900
| -5% | -$273K |
|
|
CNVR
1389
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $5.79M | ﹤0.01% |
277,891
-4,500
| -2% | -$102K |
|
1390
Bio-Rad Laboratories Class A
BIO
$9.66B
| $5.77M | ﹤0.01% |
49,090
-600
| -1% | -$70.8K |
|
|
BMS
1391
DELISTED
Bemis
BMS
| $5.77M | ﹤0.01% |
147,884
-2,100
| -1% | -$85.1K |
|
|
STLY
1392
DELISTED
Stanley Furniture Co Inc
STLY
| $5.75M | ﹤0.01% |
1,550,143
-13,900
| -0.9% | -$50K |
|
1393
Dana Inc
DAN
$3.26B
| $5.74M | ﹤0.01% |
251,400
-15,100
| -6% | -$327K |
|
|
SCR
1394
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
| $5.67M | ﹤0.01% |
599,300
| – | – |
|
|
SWI
1395
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $5.67M | ﹤0.01% |
161,700
-7,900
| -5% | -$309K |
|
1396
Raymond James Financial
RJF
$34.8B
| $5.64M | ﹤0.01% |
203,055
+3,900
| +2% | +$113K |
|
1397
Genpact
G
$5.78B
| $5.6M | ﹤0.01% |
296,712
-10,300
| -3% | -$205K |
|
1398
Nasdaq
NDAQ
$54.6B
| $5.6M | ﹤0.01% |
523,470
+16,500
| +3% | +$176K |
|
|
BZC
1399
DELISTED
BREEZE-EASTERN CORPORATION COM
BZC
| $5.54M | ﹤0.01% |
562,750
-29,047
| -5% | -$260K |
|
|
LITB
1400
LightInTheBox
LITB
$53.8M
| $5.54M | ﹤0.01% |
77,950
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.